<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30335591</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1554-8635</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Autophagy</Title><ISOAbbreviation>Autophagy</ISOAbbreviation></Journal><ArticleTitle>Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.</ArticleTitle><Pagination><StartPage>631</StartPage><EndPage>651</EndPage><MedlinePgn>631-651</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/15548627.2018.1535292</ELocationID><Abstract><AbstractText>Macroautophagy/autophagy, a defense mechanism against aberrant stresses, in neurons counteracts aggregate-prone misfolded protein toxicity. Autophagy induction might be beneficial in neurodegenerative diseases (NDs). The natural compound trehalose promotes autophagy via TFEB (transcription factor EB), ameliorating disease phenotype in multiple ND models, but its mechanism is still obscure. We demonstrated that trehalose regulates autophagy by inducing rapid and transient lysosomal enlargement and membrane permeabilization (LMP). This effect correlated with the calcium-dependent phosphatase PPP3/calcineurin activation, TFEB dephosphorylation and nuclear translocation. Trehalose upregulated genes for the TFEB target and regulator Ppargc1a, lysosomal hydrolases and membrane proteins (Ctsb, Gla, Lamp2a, Mcoln1, Tpp1) and several autophagy-related components (Becn1, Atg10, Atg12, Sqstm1/p62, Map1lc3b, Hspb8 and Bag3) mostly in a PPP3- and TFEB-dependent manner. TFEB silencing counteracted the trehalose pro-degradative activity on misfolded protein causative of motoneuron diseases. Similar effects were exerted by trehalase-resistant trehalose analogs, melibiose and lactulose. Thus, limited lysosomal damage might induce autophagy, perhaps as a compensatory mechanism, a process that is beneficial to counteract neurodegeneration. Abbreviations: ALS: amyotrophic lateral sclerosis; AR: androgen receptor; ATG: autophagy related; AV: autophagic vacuole; BAG3: BCL2-associated athanogene 3; BECN1: beclin 1, autophagy related; CASA: chaperone-assisted selective autophagy; CTSB: cathepsin b; DAPI: 4',6-diamidino-2-phenylindole; DMEM: Dulbecco's modified Eagle's medium; EGFP: enhanced green fluorescent protein; fALS, familial amyotrophic lateral sclerosis; FRA: filter retardation assay; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GLA: galactosidase, alpha; HD: Huntington disease; hIPSCs: human induced pluripotent stem cells; HSPA8: heat shock protein A8; HSPB8: heat shock protein B8; IF: immunofluorescence analysis; LAMP1: lysosomal-associated membrane protein 1; LAMP2A: lysosomal-associated membrane protein 2A; LGALS3: lectin, galactose binding, soluble 3; LLOMe: L-leucyl-L-leucine methyl ester; LMP: lysosomal membrane permeabilization; Lys: lysosomes; MAP1LC3B: microtubule-associated protein 1 light chain 3 beta; MCOLN1: mucolipin 1; mRNA: messenger RNA; MTOR: mechanistic target of rapamycin kinase; NDs: neurodegenerative diseases; NSC34: neuroblastoma x spinal cord 34; PBS: phosphate-buffered saline; PD: Parkinson disease; polyQ: polyglutamine; PPARGC1A: peroxisome proliferative activated receptor, gamma, coactivator 1 alpha; PPP3CB: protein phosphatase 3, catalytic subunit, beta isoform; RT-qPCR: real-time quantitative polymerase chain reaction; SBMA: spinal and bulbar muscular atrophy; SCAs: spinocerebellar ataxias; siRNA: small interfering RNA; SLC2A8: solute carrier family 2, (facilitated glucose transporter), member 8; smNPCs: small molecules neural progenitors cells; SOD1: superoxide dismutase 1; SQSTM1/p62: sequestosome 1; STED: stimulated emission depletion; STUB1: STIP1 homology and U-box containing protein 1; TARDBP/TDP-43: TAR DNA binding protein; TFEB: transcription factor EB; TPP1: tripeptidyl peptidase I; TREH: trehalase (brush-border membrane glycoprotein); WB: western blotting; ZKSCAN3: zinc finger with KRAB and SCAN domains 3.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rusmini</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9989-0733</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortese</LastName><ForeName>Katia</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9218-8933</Identifier><AffiliationInfo><Affiliation>b DIMES, Dipartimento di Medicina Sperimentale, Anatomia Umana , Universit&#xe0; di Genova , Genova , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crippa</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-3058-5711</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cristofani</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2719-846X</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cicardi</LastName><ForeName>Maria Elena</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0001-9490-303X</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-2514-9445</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vezzoli</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2032-4179</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedesco</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7077-3696</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meroni</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6682-4799</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messi</LastName><ForeName>Elio</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9515-1463</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piccolella</LastName><ForeName>Margherita</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5130-1116</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galbiati</LastName><ForeName>Mariarita</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3250-5591</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garr&#xe8;</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>c IFOM , Istituto FIRC di Oncologia Molecolare , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>d Dipartimento di Bioscienze , Universit&#xe0; degli Studi di Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaccari</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6231-7105</Identifier><AffiliationInfo><Affiliation>d Dipartimento di Bioscienze , Universit&#xe0; degli Studi di Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poletti</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8883-0468</Identifier><AffiliationInfo><Affiliation>a Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Centro di Eccellenza sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Milano , Milano , Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>e Centro Interuniversitario sulle Malattie Neurodegenerative , Universit&#xe0; degli Studi di Firenze , Genova e Milano , Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Autophagy</MedlineTA><NlmUniqueID>101265188</NlmUniqueID><ISSNLinking>1554-8627</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051778">Basic Helix-Loop-Helix Leucine Zipper Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C502070">MAP1LC3B protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C099718">SQSTM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071456">Sequestosome-1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C064972">TFEB protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000717268">Tpp1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000091346">Tripeptidyl-Peptidase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>B8WCK70T7I</RegistryNumber><NameOfSubstance UI="D014199">Trehalose</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.16</RegistryNumber><NameOfSubstance UI="D019703">Calcineurin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.14.9</RegistryNumber><NameOfSubstance UI="C000717267">TPP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071182" MajorTopicYN="N">Autophagosomes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051778" MajorTopicYN="N">Basic Helix-Loop-Helix Leucine Zipper Transcription Factors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019703" MajorTopicYN="N">Calcineurin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066829" MajorTopicYN="N">Neuroprotection</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071456" MajorTopicYN="N">Sequestosome-1 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014199" MajorTopicYN="N">Trehalose</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091346" MajorTopicYN="N">Tripeptidyl-Peptidase 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056811" MajorTopicYN="N">Unfolded Protein Response</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">TFEB</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">calcineurin</Keyword><Keyword MajorTopicYN="N">galectin-3</Keyword><Keyword MajorTopicYN="N">lactulose</Keyword><Keyword MajorTopicYN="N">lysosomes</Keyword><Keyword MajorTopicYN="N">melibiose</Keyword><Keyword MajorTopicYN="N">motoneuron diseases</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">protein quality control</Keyword><Keyword MajorTopicYN="N">spinal and bulbar muscular atrophy</Keyword><Keyword MajorTopicYN="N">trehalose</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30335591</ArticleId><ArticleId IdType="pmc">PMC6526812</ArticleId><ArticleId IdType="doi">10.1080/15548627.2018.1535292</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835977</ArticleId><ArticleId IdType="pubmed">26799652</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L, Bravo-San Pedro JM, Levine B, et al. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov. 2017;16:487&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5713640</ArticleId><ArticleId IdType="pubmed">28529316</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson MP, Hewitt EW.. Cellular proteostasis: degradation of misfolded proteins by lysosomes. Essays Biochem. 2016;60:173&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065703</ArticleId><ArticleId IdType="pubmed">27744333</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidar M, Timmerman V.. Autophagy as an emerging common pathomechanism in inherited peripheral neuropathies. Front Mol Neurosci. 2017;10:143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5425483</ArticleId><ArticleId IdType="pubmed">28553203</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumkwana D, Du Toit A, Kinnear C, et al. Autophagic flux control in neurodegeneration: progress and precision targeting-Where do we stand? Progr Neurobiol. 2017;153:64&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">28385648</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies FM, Fleming A, Caricasole A, et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron. 2017;93:1015&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pubmed">28279350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Rubinsztein DC.. Huntington&#x2019;s disease: degradation of mutant huntingtin by autophagy. FEBS J. 2008;275:4263&#x2013;4270.</Citation><ArticleIdList><ArticleId IdType="pubmed">18637946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Rubinsztein DC. Small molecule enhancers of autophagy for neurodegenerative diseases. Mol Biosyst. 2008;4:895&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pubmed">18704227</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Davies JE, Huang Z, et al. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem. 2007;282:5641&#x2013;5652.</Citation><ArticleIdList><ArticleId IdType="pubmed">17182613</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P, Crippa V, Giorgetti E, et al. Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy. Neurobiol Aging. 2013;34:2585&#x2013;2603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3748343</ArticleId><ArticleId IdType="pubmed">23810450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan DM, Liu FT, Zhao J, et al. Effect of trehalose on PC12 cells overexpressing wild-type or A53T mutant alpha-synuclein. Neurochem Res. 2012;37:2025&#x2013;2032.</Citation><ArticleIdList><ArticleId IdType="pubmed">22707286</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Fan H, Ying Z, et al. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system. Neurosci Lett. 2010;469:112&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">19944744</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguib Y, Heiseke A, Gilch S, et al. Autophagy induction by trehalose counteracts cellular prion infection. Autophagy. 2009;5:361&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">19182537</ArticleId></ArticleIdList></Reference><Reference><Citation>Casarejos MJ, Perucho J, Lopez-Sendon JL, et al. Trehalose improves human fibroblast deficits in a new CHIP-mutation related ataxia. PloS one. 2014;9:e106931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178022</ArticleId><ArticleId IdType="pubmed">25259530</ArticleId></ArticleIdList></Reference><Reference><Citation>He Q, Koprich JB, Wang Y, et al. Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV alpha-synuclein rat model of Parkinson&#x2019;s disease. Mol Neurobiol. 2016;53:2258&#x2013;2268.</Citation><ArticleIdList><ArticleId IdType="pubmed">25972237</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Chen S, Song L, et al. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy. 2014;10:588&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4091147</ArticleId><ArticleId IdType="pubmed">24441414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Chigurupati S, Raymick J, et al. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson&#x2019;s disease mouse model. Neurotoxicology. 2014;44:250&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">25064079</ArticleId></ArticleIdList></Reference><Reference><Citation>Du J, Liang Y, Xu F, et al. Trehalose rescues Alzheimer&#x2019;s disease phenotypes in APP/PS1 transgenic mice. J Pharm Pharmacol. 2013;65:1753&#x2013;1756.</Citation><ArticleIdList><ArticleId IdType="pubmed">24236985</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo K, Nassif M, Valenzuela V, et al. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy. 2013;9:1308&#x2013;1320.</Citation><ArticleIdList><ArticleId IdType="pubmed">23851366</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeffer V, Lavenir I, Ozcelik S, et al. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain. 2012;135:2169&#x2013;2177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381726</ArticleId><ArticleId IdType="pubmed">22689910</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeffer V, Goedert M. Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy. 2012;8:1686&#x2013;1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3494601</ArticleId><ArticleId IdType="pubmed">22874558</ArticleId></ArticleIdList></Reference><Reference><Citation>Perucho J, Casarejos MJ, Gomez A, et al. Trehalose protects from aggravation of amyloid pathology induced by isoflurane anesthesia in APP(swe) mutant mice. Curr Alzheimer Res. 2012;9:334&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">22272607</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Navarro JA, Rodriguez L, Casarejos MJ, et al. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation. Neurobiol Dis. 2010;39:423&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">20546895</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies JE, Sarkar S, Rubinsztein DC. Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Hum Mol Genet. 2006;15:23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">16311254</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M, Machida Y, Niu S, et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med. 2004;10:148&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">14730359</ArticleId></ArticleIdList></Reference><Reference><Citation>Debnath K, Pradhan N, Singh BK, et al. Poly(trehalose) nanoparticle prevents amyloid aggregation and suppress polyglutamine aggregation in huntington&#x2019;s disease model mouse. ACS Appl Mater Inter. 2017;9:24126&#x2013;24139.</Citation><ArticleIdList><ArticleId IdType="pubmed">28632387</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgetti E, Rusmini P, Crippa V, et al. Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy. Hum Mol Genet. 2015;24:64&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4262493</ArticleId><ArticleId IdType="pubmed">25122660</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Li M, Li L, et al. Trehalose, sucrose and raffinose are novel activators of autophagy in human keratinocytes through an mTOR-independent pathway. Sci Rep. 2016;6:28423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4916512</ArticleId><ArticleId IdType="pubmed">27328819</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie HL, Merry DE. Autophagy and access: understanding the role of androgen receptor subcellular localization in SBMA. Autophagy. 2009;5:1194&#x2013;1197.</Citation><ArticleIdList><ArticleId IdType="pubmed">19770590</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri M, Pal R, Nelvagal HR, et al. mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun. 2017;8:14338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5303831</ArticleId><ArticleId IdType="pubmed">28165011</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardones P, Rubinsztein DC, Hetz C. Mystery solved: trehalose kickstarts autophagy by blocking glucose transport. Sci Signal. 2016;9:fs2.</Citation><ArticleIdList><ArticleId IdType="pubmed">26905424</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBosch BJ, Heitmeier MR, Mayer AL, et al. Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis. Sci Signal. 2016;9:ra21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4816640</ArticleId><ArticleId IdType="pubmed">26905426</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer AL, Higgins CB, Heitmeier MR, et al. SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy. Sci Rep. 2016;6:38586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5138640</ArticleId><ArticleId IdType="pubmed">27922102</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehay B, Bove J, Rodriguez-Muela N, et al. Pathogenic lysosomal depletion in Parkinson&#x2019;s disease. J Neurosci. 2010;30:12535&#x2013;12544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6633458</ArticleId><ArticleId IdType="pubmed">20844148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardiello M, Palmieri M, di Ronza A, et al. A gene network regulating lysosomal biogenesis and function. Science. 2009;325:473&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pubmed">19556463</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina DL, Fraldi A, Bouche V, et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell. 2011;21:421&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173716</ArticleId><ArticleId IdType="pubmed">21889421</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri M, Impey S, Kang H, et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet. 2011;20:3852&#x2013;3866.</Citation><ArticleIdList><ArticleId IdType="pubmed">21752829</ArticleId></ArticleIdList></Reference><Reference><Citation>Settembre C, Ballabio A. TFEB regulates autophagy: an integrated coordination of cellular degradation and recycling processes. Autophagy. 2011;7:1379&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pubmed">21785263</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina DL, Ballabio A. Lysosomal calcium regulates autophagy. Autophagy. 2015;11:970&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4502748</ArticleId><ArticleId IdType="pubmed">26000950</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina DL, Di Paola S, Peluso I, et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol. 2015;17:288&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4801004</ArticleId><ArticleId IdType="pubmed">25720963</ArticleId></ArticleIdList></Reference><Reference><Citation>Valero T. Mitochondrial biogenesis: pharmacological approaches. Cur Pharm Design. 2014;20:5507&#x2013;5509.</Citation><ArticleIdList><ArticleId IdType="pubmed">24606795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchis-Gomar F, Garcia-Gimenez JL, Gomez-Cabrera MC, et al. Mitochondrial biogenesis in health and disease. Molecular and Therapeutic Approaches. Cur Pharm Design. 2014;20:5619&#x2013;5633.</Citation><ArticleIdList><ArticleId IdType="pubmed">24606801</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorn GW II, Vega RB, Kelly DP. Mitochondrial biogenesis and dynamics in the developing and diseased heart. Gene Dev. 2015;29:1981&#x2013;1991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4604339</ArticleId><ArticleId IdType="pubmed">26443844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan S, Goodwin JG, Chauhan S, et al. ZKSCAN3 is a master transcriptional repressor of autophagy. Molecular Cell. 2013;50:16&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628091</ArticleId><ArticleId IdType="pubmed">23434374</ArticleId></ArticleIdList></Reference><Reference><Citation>Arndt V, Dick N, Tawo R, et al. Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol. 2010;20:143&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">20060297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettern N, Rogon C, Limmer A, et al. The Hsc/Hsp70 co-chaperone network controls antigen aggregation and presentation during maturation of professional antigen presenting cells. PloS one. 2011;6:e16398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024426</ArticleId><ArticleId IdType="pubmed">21283720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulbricht A, Gehlert S, Leciejewski B, et al. Induction and adaptation of chaperone-assisted selective autophagy CASA in response to resistance exercise in human skeletal muscle. Autophagy. 2015;11:538&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4502687</ArticleId><ArticleId IdType="pubmed">25714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaoui R, Palmio J, Brewer J, et al. Mutations in HSPB8 causing a new phenotype of distal myopathy and motor neuropathy. Neurology. 2016;86:391&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4776089</ArticleId><ArticleId IdType="pubmed">26718575</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R, Crippa V, Rusmini P, et al. Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases. Autophagy. 2017;13:1280&#x2013;1303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5584856</ArticleId><ArticleId IdType="pubmed">28402699</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P, Crippa V, Cristofani R, et al. The role of the protein quality control system in SBMA. J Mol Neurosci. 2016;58:348&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">26572535</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P, Cristofani R, Galbiati M, et al. The role of the Heat Shock Protein B8 (HSPB8) in motoneuron diseases. Front Mol Neurosci. 2017;10:176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5478700</ArticleId><ArticleId IdType="pubmed">28680390</ArticleId></ArticleIdList></Reference><Reference><Citation>Behl C. Breaking BAG: the co-chaperone BAG3 in health and disease. Trends Pharmacol Sci. 2016;37:672&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">27162137</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamerdinger M, Kaya AM, Wolfrum U, et al. BAG3 mediates chaperone-based aggresome-targeting and selective autophagy ofmisfolded proteins. EMBO Rep. 2011;12:149&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3049430</ArticleId><ArticleId IdType="pubmed">21252941</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamerdinger M, Carra S, Behl C. Emerging roles of molecular chaperones and co-chaperones in selective autophagy: focus on BAG proteins. J Mol Med. 2011;89:1175&#x2013;1182.</Citation><ArticleIdList><ArticleId IdType="pubmed">21818581</ArticleId></ArticleIdList></Reference><Reference><Citation>Simeoni S, Mancini MA, Stenoien DL, et al. Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet. 2000;9:133&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">10587588</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccioni F, Pinton P, Simeoni S, et al. Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes. FASEB J. 2002;16:1418&#x2013;1420.</Citation><ArticleIdList><ArticleId IdType="pubmed">12205033</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti A. The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons. Front Neuroendocrinol. 2004;25:1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">15183036</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P, Sau D, Crippa V, et al. Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy. Neurobiol Aging. 2007;28:1099&#x2013;1111.</Citation><ArticleIdList><ArticleId IdType="pubmed">16781019</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P, Bolzoni E, Crippa V, et al. Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy. Neurobiol Dis. 2010;40:361&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">20621188</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P, Simonini F, Crippa V, et al. 17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy. Neurobiol Dis. 2011;41:83&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">20816782</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R, Crippa V, Vezzoli G, et al. The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases. Cell Stress Chaperon. 2017. DOI:10.1007/s12192-017-0806-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-017-0806-9</ArticleId><ArticleId IdType="pmc">PMC5741577</ArticleId><ArticleId IdType="pubmed">28608264</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V, Sau D, Rusmini P, et al. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet. 2010;19:3440&#x2013;3456.</Citation><ArticleIdList><ArticleId IdType="pubmed">20570967</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V, Cicardi ME, Ramesh N, et al. The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity. Hum Mol Genet. 2016;25:3908&#x2013;3924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5291228</ArticleId><ArticleId IdType="pubmed">27466192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R, Fani G, Capitini C, et al. Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy. FASEB J. 2017. DOI:10.1096/fj.201700292RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700292RR</ArticleId><ArticleId IdType="pubmed">28842427</ArticleId></ArticleIdList></Reference><Reference><Citation>Zydowsky LD, Etzkorn FA, Chang HY, et al. Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci. 1992;1:1092&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2142182</ArticleId><ArticleId IdType="pubmed">1338979</ArticleId></ArticleIdList></Reference><Reference><Citation>Aits S, Kricker J, Liu B, et al. Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay. Autophagy. 2015;11:1408&#x2013;1424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4590643</ArticleId><ArticleId IdType="pubmed">26114578</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz I, Sachse M, Dupont N, et al. Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell Microbiol. 2010;12:530&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pubmed">19951367</ArticleId></ArticleIdList></Reference><Reference><Citation>Maejima I, Takahashi A, Omori H, et al. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. Embo J. 2013;32:2336&#x2013;2347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3770333</ArticleId><ArticleId IdType="pubmed">23921551</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudmand-Hoyer E, Fenger HJ, Skovbjerg H, et al. Trehalase deficiency in Greenland. Scand J Gastroenterol. 1988;23:775&#x2013;778.</Citation><ArticleIdList><ArticleId IdType="pubmed">3227291</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CH, Wu YR, Yang JM, et al. Novel lactulose and melibiose targeting autophagy to reduce PolyQ aggregation in cell models of spinocerebellar ataxia 3. CNS Neurol Disord-DR. 2016;15:351&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">26295831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee GC, Lin CH, Tao YC, et al. The potential of lactulose and melibiose, two novel trehalase-indigestible and autophagy-inducing disaccharides, for polyQ-mediated neurodegenerative disease treatment. Neurotoxicology. 2015;48:120&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">25800379</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Muela N, Hernandez-Pinto AM, Serrano-Puebla A, et al. Lysosomal membrane permeabilization and autophagy blockade contribute to photoreceptor cell death in a mouse model of retinitis pigmentosa. Cell Death Differ. 2015;22:476&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4326579</ArticleId><ArticleId IdType="pubmed">25501597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan S, Kumar S, Jain A, et al. TRIMs and galectins globally cooperate and TRIM16 and galectin-3 co-direct autophagy in endomembrane damage homeostasis. Dev Cell. 2016;39:13&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5104201</ArticleId><ArticleId IdType="pubmed">27693506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Chauhan S, Jain A, et al. Galectins and TRIMs directly interact and orchestrate autophagic response to endomembrane damage. Autophagy. 2017:1&#x2013;2. DOI:10.1080/15548627.2017.1307487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1307487</ArticleId><ArticleId IdType="pmc">PMC5486367</ArticleId><ArticleId IdType="pubmed">28368693</ArticleId></ArticleIdList></Reference><Reference><Citation>Anding AL, Baehrecke EH. Cleaning house: selective autophagy of organelles. Dev Cell. 2017;41:10&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5395098</ArticleId><ArticleId IdType="pubmed">28399394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawabata T, Yoshimori T. Beyond starvation: an update on the autophagic machinery and its functions. J Mol Cell Cardiol. 2016;95:2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">26682507</ArticleId></ArticleIdList></Reference><Reference><Citation>Settembre C, Medina DL. TFEB and the CLEAR network. Methods Cell Biol. 2015;126:45&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">25665440</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Xu YF, Cook C, et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U.S.A. 2009;106:7607&#x2013;7612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V, Carra S, Rusmini P, et al. A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases. Autophagy. 2010;6:958&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pubmed">20699640</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman NR, Durham HD, Blusztajn JK, et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Devel Dyn. 1992;194:209&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham HD, Dahrouge S, Cashman NR. Evaluation of the spinal cord neuron X neuroblastoma hybrid cell line NSC-34 as a model for neurotoxicity testing. Neurotoxicol. 1992;14:387&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">7909362</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt P, Glatza M, Hemmer K, et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PloS one. 2013;8:e59252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3606479</ArticleId><ArticleId IdType="pubmed">23533608</ArticleId></ArticleIdList></Reference><Reference><Citation>Thellung S, Scoti B, Corsaro A, et al. Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death. Cell Death Dis. 2018;9:166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833808</ArticleId><ArticleId IdType="pubmed">29416016</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>